Literature DB >> 519904

Neuraminidase deficiency in the original patient with the Goldberg syndrome.

G H Thomas, M F Goldberg, C S Miller, L W Reynolds.   

Abstract

Homogenates of cultured skin fibroblasts from a non-ambulatory, 20-year-old male with cherry-red spots, corneal clouding, seizures, mental retardation, dysostosis multiplex, dwarfism, coarse facies and loss of vision, originally described by Goldberg et al. (1971), have diminished neuraminidase activity and an excess of neuraminic acid-rich compounds. Specifically, these cells have 2-17% normal neuraminidase when measured with 2-(3' methoxyphenyl)-N-acetyl-alpha-neuraminic acid, N-acetyl-neuramin-lactose and fetuin. Activities of 12 other lysosomal enzymes were either at or above the range of normal control fibroblasts. Total neuraminic acid concentration was 44.3 nmol/mg protein versus an average control value of 14.2. It is concluded that the Goldberg syndrome should be considered, along with mucolipidosis I and the cherry-red spot -- myoclonus syndrome, as resulting from a primary neuraminidase deficiency.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 519904     DOI: 10.1111/j.1399-0004.1979.tb01010.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  10 in total

1.  Accumulation of [3H]sialyl-conjugates in sialidosis (sialidase-deficient) fibroblasts cultured in the presence of [3H]-N-acetylmannosamine.

Authors:  J Scocca; G H Thomas; L Reynolds; C S Miller
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

2.  Sialidosis and galactosialidosis: chromosomal assignment of two genes associated with neuraminidase-deficiency disorders.

Authors:  O T Mueller; W M Henry; L L Haley; M G Byers; R L Eddy; T B Shows
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

3.  The simple detection of neuraminic acid-containing urinary oligosaccharides in patients with glycoprotein storage diseases.

Authors:  A C Sewell
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

4.  Infantile type 2 sialidosis in a Pakistani family--a clinical and biochemical study.

Authors:  M King; F Cockburn; G B MacPhee; R W Logan
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

5.  A severe infantile sialidosis (beta-galactosidase-alpha-neuraminidase deficiency) mimicking GM1-gangliosidosis type 1.

Authors:  S Okada; H Sugino; T Kato; T Yutaka; M Koike; T Dezawa; T Yamano; H Yabuuchi
Journal:  Eur J Pediatr       Date:  1983-09       Impact factor: 3.183

6.  Combined deficiency of beta-galactosidase and neuraminidase: three affected siblings in a French family.

Authors:  I Maire; A R Nivelon-Chevallier
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

7.  Neuraminidase deficiency: case report and review of the phenotype.

Authors:  I D Young; E P Young; J Mossman; A R Fielder; J R Moore
Journal:  J Med Genet       Date:  1987-05       Impact factor: 6.318

8.  beta-Galactosidase-neuraminidase deficiency in adults: deficiency of a freeze-labile neuraminidase in leukocytes and fibroblasts.

Authors:  Y Suzuki; H Sakuraba; M Potier; M Akagi; M Sakai; H Beppu
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

9.  Human beta-galactosidase and alpha-neuraminidase deficient mucolipidosis: genetic complementation analysis of the neuraminidase deficiency.

Authors:  O T Mueller; T B Shows
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

10.  Cherry-red spot myoclonus syndrome and alpha-neuraminidase deficiency: neurophysiological, pharmacological and biochemical study in an adult.

Authors:  S Franceschetti; G Uziel; S Di Donato; L Caimi; G Avanzini
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-10       Impact factor: 10.154

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.